Mumbai’s Luma Fertility raises US$4m seed round

A Mumbai-based fertility health-tech startup has raised US$4m in seed funding to expand its services across the city and into other parts of India.

Luma Fertility will use the investment to expand its footprint in Mumbai and later scale into other cities over the next two years.

The startup operates a 6,000-square-foot facility housing a laboratory and offering a range of in-house fertility services.

Its offerings include IVF, egg and embryo freezing, fertility assessments and pre-conception consultations.

Luma also provides at-home semen analysis, personalised fertility reports and holistic support such as nutrition guidance, acupuncture, IV drips and one-on-one sessions to support both physical and emotional well-being and improve overall outcomes.

The funding round was led by Peak XV’s Surge, with participation from Ameera Shah of Metropolis Healthcare and Vijay Taparia of B2V Ventures.

Ameera Shah, promoter and executive chairperson of Metropolis Healthcare, said: “Fertility care in India is at an inflection point. Demand is growing rapidly, but the system is deeply fragmented and outdated. Patients are forced to navigate a maze of clinics, labs, and specialists with little coordination or support.”

Founded by Neha K. Motwani, Luma says it is the first IVF clinic in India to launch an integrated app, allowing patients to track their treatment, access reports and stay informed.

Its AI-enabled tool, LumaAI, offers 24/7, jargon-free support on everything from cycle timelines to medication guidance.

The global fertility services market is projected to reach US$53bn by 2030, driven by delayed parenthood, increasing age-related infertility and declining fertility rates.

In India, the total fertility rate has declined from 2.1 to 1.9 births per woman – the lowest on record.

More than 33 million couples in India are estimated to face fertility challenges, with IVF cycles expected to increase from 320,000 in 2024 to 550,000 by 2028.